COX-2 Inhibitor Usage Guidelines

Patient Selection

The American College of Gastroenterology recommends selecting COX-2 inhibitors for patients on aspirin without prior GI events, or for those with prior GI events not on aspirin, while using traditional NSAIDs only in patients under 65 years without GI risk factors and not on aspirin 1, 2
For patients with low GI risk (age <65, no prior GI events, no aspirin), the American Gastroenterological Association suggests using traditional NSAID alone, which is the only scenario where traditional NSAIDs without gastroprotection are appropriate 1, 2, 3
In patients with moderate GI risk, the American College of Gastroenterology recommends using COX-2 inhibitor or traditional NSAID + PPI if on aspirin but no prior GI event, or if prior GI event but not on aspirin 1, 2

The American Heart Association notes that COX-2 inhibitors increase cardiovascular thrombotic events, including MI and stroke, which can be fatal, with a risk that appears within weeks of treatment and is dose-dependent 6
For patients with known CV disease or recent CV events, the American College of Cardiology advises avoiding COX-2 inhibitors if possible, and using the lowest effective dose for the shortest duration if necessary 6
The American College of Cardiology also recommends that patients requiring aspirin for cardioprotection should not use COX-2 inhibitors, as they lose their GI advantage when combined with aspirin, and may prolong recovery from gastric mucosal injury 6, 7

The American Gastroenterological Association states that traditional NSAID alone should never be used in patients with prior GI bleeding, perforation, obstruction, or ulcer, concomitant aspirin use, or age ≥65 with any additional risk factor 1, 3, 2
The American College of Gastroenterology advises that COX-2 inhibitor alone should never be used in patients with prior GI event AND aspirin use, or aspirin + steroids/warfarin 4, 3, 1
The American Heart Association recommends monitoring blood pressure at initiation and throughout treatment, as both COX-1 and COX-2 inhibitors can cause new-onset hypertension or worsen existing hypertension 6